Continuous Glucose Monitoring in Type 2 Diabetes Mellitus

Completed

Conditions studied: Diabetic Vascular Complications

In brief

It is well known that lowering average blood glucose decreases the risk of diabetic complications involving the small vessels, such as those found in the eyes, nerves and kidney. It is less clear however, if controlling fluctuations in blood glucose will further help to prevent such complications. The purpose of this study is to examine the relationship between extreme fluctuations in glucose and damage to the blood vessel lining.

Key facts

Study ID

NCT01083043

Run by

NYU Langone Health

People needed

28

Starts

2006-12-01

Expected to finish

2011-03-01

Last updated by the study team

2019-02-06

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult subjects with Type 2 Diabetes Mellitus and glycosylated hemoglobin <8.0%

You may not qualify if…

• Age <18 or >65
• BMI >35
• Pregnant
• Baseline glycosylated hemoglobin <6.0% or >8.0%
• Winthrop University Hospital Employee or Staff member
• Vulnerable subject
• Uncontrolled hypertension(defined as systolic blood pressure >130 or diastolic blood pressure >80mmHg)
• Uncontrolled dyslipidemia (defined as LDL >130mg/dL; HDL <30mg/dL or triglycerides >199mg/dL)
• Current smoker or significant smoke exposure(defined as greater than 2 hours of exposure to second-hand smoke within the preceding 48hrs)
• Sympathomimetic use within the past week
• History of cardiovascular disease
• History of paroxysmal nocturnal hemoglobinuria
• History of thrombotic thrombocytopenic purpura
• History of stage II-V Chronic Kidney Disease

Where it is running

• Winthrop University Hospital — Mineola, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.